ENROXIL MAX 100 MG/ML SOLUTION FOR INJECTION FOR CATTLE
Land: Irland
Sprog: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Produktets egenskaber
(SPC)
12-06-2015
Nogle dokumenter til dette produkt er ikke tilgængelige i øjeblikket, du kan sende en anmodning til vores kundeservice, og vi vil underrette dig, så snart vi er i stand til at få dem.
Send anmodning.
Send anmodning.
Aktiv bestanddel:
ENROFLOXACIN
Tilgængelig fra:
Krka, d.d., Novo mesto
ATC-kode:
QJ01MA90
INN (International Name):
ENROFLOXACIN
Dosering:
100 Mg/Ml
Lægemiddelform:
Solution for Injection
Recept type:
POM
Terapeutisk gruppe:
Bovine
Terapeutisk område:
Enrofloxacin
Terapeutiske indikationer:
Antibacterial
Autorisation status:
Authorised
Autorisation dato:
2008-09-19
Produktets egenskaber
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Enroxil Max 100 mg/ml solution for injection for cattle.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of bovine respiratory disease associated with _Mannheimia haemolytica_, _Pasteurella multocida_, _Histophilus_
_somni _and _Mycoplasma _spp. where clinical experience, supported where possible by sensitivity testing of the causal
organism, indicates enrofloxacin as the drug of choice.
Treatment of local signs (inflammation, milk quality and yield) associated with peracute/acute mastitis in lactating
dairy cattle caused by _E. coli_, where herd history and previous sensitivity testing indicate enrofloxacin as the drug of
choice.
4.3 CONTRAINDICATIONS
Do not use for prophylaxis.
Do not administer in case of hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
ACTIVE SUBSTANCE
Enrofloxacin
100 mg
EXCIPIENTS
Benzyl alcohol (E1519)
20 mg
Butyl alcohol
30 mg
For a full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 28/05/2015_
_CRN 7020775_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Normal sterile precautions should be taken.
The safety of the product has not been established in calves when administered by the intravenous route and use of this
route of administration in calves is therefore not recommended.
Official and local antimicrobial policies should be taken into account w
Læs hele dokumentet
